19-55159436-C-T
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1
The NM_001256715.2(DNAAF3):c.1252G>A(p.Val418Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000661 in 1,613,886 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V418A) has been classified as Uncertain significance.
Frequency
Consequence
NM_001256715.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001256715.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| DNAAF3 | NM_001256715.2 | MANE Select | c.1252G>A | p.Val418Met | missense | Exon 12 of 12 | NP_001243644.1 | ||
| DNAAF3 | NM_001256714.1 | c.1453G>A | p.Val485Met | missense | Exon 12 of 12 | NP_001243643.1 | |||
| DNAAF3 | NM_178837.4 | c.1393G>A | p.Val465Met | missense | Exon 12 of 12 | NP_849159.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| DNAAF3 | ENST00000524407.7 | TSL:1 MANE Select | c.1252G>A | p.Val418Met | missense | Exon 12 of 12 | ENSP00000432046.3 | ||
| DNAAF3 | ENST00000455045.5 | TSL:1 | c.1090G>A | p.Val364Met | missense | Exon 12 of 12 | ENSP00000394343.1 | ||
| DNAAF3 | ENST00000528412.5 | TSL:1 | n.*1040G>A | non_coding_transcript_exon | Exon 12 of 12 | ENSP00000433826.2 |
Frequencies
GnomAD3 genomes AF: 0.000374 AC: 57AN: 152224Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000281 AC: 70AN: 249226 AF XY: 0.000318 show subpopulations
GnomAD4 exome AF: 0.000690 AC: 1009AN: 1461544Hom.: 0 Cov.: 31 AF XY: 0.000641 AC XY: 466AN XY: 727024 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000374 AC: 57AN: 152342Hom.: 0 Cov.: 32 AF XY: 0.000376 AC XY: 28AN XY: 74500 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Uncertain:1Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 485 of the DNAAF3 protein (p.Val485Met). This variant is present in population databases (rs201231901, gnomAD 0.06%). This variant has not been reported in the literature in individuals affected with DNAAF3-related conditions. ClinVar contains an entry for this variant (Variation ID: 410291). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt DNAAF3 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at